The MarketWatch News Department was not involved in the creation of this content.

December 03, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / December 3, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Turquoise Hill Resources Ltd. (NYSE:TRQ)

Investors Affected : July 17, 2018 – July 31, 2019

A class action has commenced on behalf of certain shareholders in Turquoise Hill Resources Ltd. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the progress of underground development of Oyu Tolgoi was not proceeding as planned; (ii) there were significant undisclosed underground stability issues that called into question the design of the mine, the projected cost and timing of production; (iii) the company’s publicly disclosed estimates of the cost, date of completion and dates for production from the underground mine were not achievable; (iv) the development capital required for the underground development of Oyu Tolgoi would cost substantially more than a billion dollars over what the company had represented; and (v) Turquoise Hill would require additional financing and/or equity to complete the project.

Shareholders may find more information at https://securitiesclasslaw.com/securities/turquoise-hill-resources-ltd-loss-submission-form/?id=11337&from=1

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

Investors Affected : September 28, 2019 – October 7, 2020

A class action has commenced on behalf of certain shareholders in Intercept Pharmaceuticals, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Defendants downplayed the true scope and severity of safety concerns associated with the use of Ocaliva (obeticholic acid (“OCA”)), Intercept’s lead product candidate, in treating primary biliary cholangitis; (ii) the foregoing increased the likelihood of a U.S. Food and Drug Administration (“FDA”) investigation into Ocaliva’s development, thereby jeopardizing Ocaliva’s continued marketability and the sustainability of its sales; (iii) any purported benefits associated with OCA’s efficacy in treating nonalcoholic steatohepatitis (“NASH”) were outweighed by the risks of its use; (iv) as a result, the FDA was unlikely to approve the Company’s New Drug Application for OCA in treating patients with liver fibrosis due to NASH; and (v) as a result of all the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/intercept-pharmaceuticals-inc-loss-submission-form/?id=11337&from=1

Alibaba Group Holding Limited (NYSE:BABA)

Investors Affected : October 21, 2020 – November 3, 2020

A class action has commenced on behalf of certain shareholders in Alibaba Group Holding Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Ant Small and Micro Financial Services Group Co., Ltd. (“Ant Group”), a financial technology company in which Alibaba owns a 33% equity interest, did not meet listing qualifications or disclosure requirements for certain material matters; (2) certain impending changes in the Fintech regulatory environment would impact Ant Group’s business; (3) as a result of the foregoing, Ant Group’s initial public offering was reasonably likely to be suspended; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/alibaba-group-holding-limited-loss-submission-form/?id=11337&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: [email protected]: (212) 537-9430Fax: (833) 862-7770

SOURCE: The Gross Law Firm

View source version on accesswire.com: https://www.accesswire.com/619364/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-TRQ-ICPT-and-BABA

COMTEX_375480792/2457/2020-12-03T10:00:26

Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

Copyright 2020 ACCESSWIRE

The MarketWatch News Department was not involved in the creation of this content.

Source Article